EGFL8 and cancer: Notably, EGFL8 expression is downregulated in gastric and colorectal cancers, and this downregulation is significantly correlated with peritoneal dissemination and high tumor–node–metastasis (TNM) stage, highlighting its potential role in cancer development [21,22].